• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Clinuvel Pharmaceuticals Ltd

+ Add to Watchlist

CUV:AU

2.3800 AUD 0.0700 3.03%

As of 02:11:02 ET on 08/20/2014.

Snapshot for Clinuvel Pharmaceuticals Ltd (CUV)

Open: 2.3400 Day's Range: 2.3300 - 2.3900 Volume: 15,498
Previous Close: 2.3100 52wk Range: 0.8800 - 2.3900 1-Yr Rtn: +32.96%

Stock Chart for CUV

No chart data available.
  • CUV:AU 2.3800
  • 1D
  • 1M
  • 1Y
2.3100
Interactive CUV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CUV

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.1540
Est. EPS (AUD) (06/2014) -
Est. PEG Ratio -
Market Cap (M AUD) 101.07
Shares Outstanding (M) 42.47
30 Day Average Volume 89,153
Price/Book (mrq) 8.3728
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CUV

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for CUV

Clinuvel Pharmaceuticals Limited is an Australian biopharmaceutical company. The company focused on developing dermatology pharmaceutical products for a range of UV-related skin disorders. Clinuvel's work aims at preventing the symptoms of diseases related to harmful UV radiation.

Philippe J WolgenCEO/Managing DirectorDarren M KeamyCFO/Secretary
Dennis J WrightActing Chief Scientific OfcrDavina GunnMgr:Investor Rels & Marketing
More Company Profile & Key Executives for CUV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil